XSES
OU8
Market cap822mUSD
Oct 30, Last price
1.25SGD
1D
0.00%
1Q
-19.87%
Jan 2017
282.26%
Name
Centurion Corp Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Butong Group, operating through its various subsidiaries, specializes in the comprehensive lifecycle of nursery products, encompassing their design, manufacture, sale, and ongoing research and development. Their extensive product line includes essential travel accessories for infants, such as prams, child safety seats, and baby carriers. For sleep and comfort, they offer items like cots, infant apparel, and specialized pillows. Mealtime solutions provided consist of highchairs and tableware sets, while their baby care range features necessities such as nappies and cleansing wipes. Beyond product creation, Butong Group is actively involved in online retail, various marketing and promotional efforts, and delivers comprehensive after-sales services. The company was founded in 2018 and is based in Shanghai, China.
Key people
Seng Juan Han
Joint Non-Executive Chairman of the Board · since 2019
Chee Min Kong
Chief Executive Officer · since 2015
Executive Deputy Chairman of the Board · since 2019
Ai Huey Foo
Chief Financial Officer · since 2011
Lip Chin Ho
Chief Investment Officer - Accommodation Business · since 2015
Joint Executive Chairman of the Board · since 2021
Executive Director, Chief Operating Officer - Accommodation Business · since 2018
Geok Ing Lee
Human Resource & Administration Manager · since 2007
Siew Fatt Leong
Head - Student Accommodation Business · since 2021
Company Secretary · since 2015
Beng Hwee Tan
Company Secretary · since 2017
Non-Executive Independent Director · since 2024
Ming Leong Kong
Non-Executive Independent Director · since 2024
Independent Non-Executive Director · since 2019
Lead Non-Executive Independent Director · since 2026
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||